Back

Impact of serum fibrinogen on 2-year mortality following percutaneous coronary intervention--a large cohort study from china

28 August 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 6 - Coronary artery disease: diagnosis, pharmacotherapy and revascularisation Treatment, Other ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Ping Jiang

Fuwai Hospital, CAMS and PUMC, Beijing (China)

19 More presentations in this session

Presentation thumbnail
Professor J. Lee (Daegu, KR)
Abstract
Presentation thumbnail
Doctor M. Park (Daejeon, KR)
Abstract Slides
Presentation thumbnail
Professor M. Glezer (Moscow, RU)
Abstract
Presentation thumbnail
Professor A. Hassan (Assiut, EG)
Abstract Slides
Presentation thumbnail
Professor R. Januszek (Krakow, PL)
Abstract

Access the full session

Session thumbnail
Poster Session 6 - Coronary artery disease: diagnosis, pharmacotherapy and revascularisation

The Event

Event poster

ESC Congress 2018

28 August 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Impact of fibrin and atheroma on prognosis in acute coronary syndrome: Insights from thrombectomy specimens
1 September 2025
thumbnail
Congress Presentation
High-sensitivity C-Reactive protein predicts post-percutaneous coronary intervention cardiovascular risk with bmi threshold effect: evidence from a prospective registry study
31 August 2025
thumbnail
Congress Presentation
Tissue factor, a membrane-associated biomarker of platelet activation, predicts 5-year cardiovascular mortality in coronary artery disease patients
1 September 2025
thumbnail
Congress Presentation
Association between platelet reactivity and long-term bleeding complications following percutaneous coronary intervention in patients with and without diabetes
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources